Literature DB >> 33762658

Location of ischemia and ischemic pain intensity affect spatiotemporal parameters and leg muscles activity during walking in patients with intermittent claudication.

Céline Guilleron1,2,3, Pierre Abraham4,2, Bruno Beaune1, Camille Pouliquen1, Samir Henni2,3, Sylvain Durand5,6.   

Abstract

The ways in which locations of ischemia and ischemic pain affect spatiotemporal gait parameters and leg electromyographic activity during walking have never been investigated in patients with peripheral arterial disease presenting intermittent claudication. Two groups were classified according to unilateral location of ischemia (distal, n = 10, or proximo-distal, n = 12). Patients described pain and three gait phases-initial pain-free, onset of pain and maximum pain-were analyzed. Patients with proximo-distal ischemia walked less (230 ± 111 m vs 384 ± 220 m), with increased step length, step time (+ 5.4% and + 5.8%) and reduced cadence (- 8.2%), than patients with distal ischemia. In both, the peaks of vertical ground reaction force were reduced in maximum pain (Peak1-distal: - 11.4%, Peak1-proximo-distal: - 10.3%; Peak2-distal: - 11.8%, Peak2-proximo-distal: - 9.0%). In the proximo-distal group, tibialis anterior activation peak and time were lower than in the distal group (- 4.5% and - 19.7%). During the maximum pain phase, this peak decreased only in the proximo-distal group (- 13.0%), and gastrocnemius medialis activation peak and time decreased in both groups (- 2.5% in distal and - 4.5% in proximo-distal). Thus, proximo-distal ischemia leads to more adverse consequences in gait than distal ischemia only. Increasing ischemic pain until maximum, but not onset of pain, induced gait adaptations.

Entities:  

Year:  2021        PMID: 33762658     DOI: 10.1038/s41598-021-86351-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  6 in total

Review 1.  Cardiac resynchronization therapy for heart failure.

Authors:  William T Abraham; David L Hayes
Journal:  Circulation       Date:  2003-11-25       Impact factor: 29.690

2.  Repeated measurement of Mo2 in small aquatic organisms: a manual intermittent flow respirometer using off-the-shelf components.

Authors:  Daniel W Baker; Michael E Hudson; Emily J Frost; Mary A Sewell
Journal:  J Appl Physiol (1985)       Date:  2017-12-06

3.  Proximal ischemia is a frequent cause of exercise-induced pain in patients with a normal ankle to brachial index at rest.

Authors:  Marie Gernigon; Johann Marchand; Nafi Ouedraogo; Georges Leftheriotis; Jean M Piquet; Pierre Abraham
Journal:  Pain Physician       Date:  2013-01       Impact factor: 4.965

4.  High prevalence of exercise-induced ischemia in the asymptomatic limb of patients with apparently strictly unilateral symptoms and unilateral peripheral artery disease.

Authors:  Samir Henni; Pascal Bauer; Tanguy Le Meliner; Jeanne Hersant; Xavier Papon; Mickael Daligault; Jean-Marie Chretien; Myriam Ammi; Jean Picquet; Pierre Abraham
Journal:  Ther Adv Cardiovasc Dis       Date:  2019 Jan-Dec

5.  Gait pattern in patients with peripheral artery disease.

Authors:  Maria Szymczak; Paweł Krupa; Grzegorz Oszkinis; Marian Majchrzycki
Journal:  BMC Geriatr       Date:  2018-02-20       Impact factor: 3.921

6.  Influence of the Physical Training on Muscle Function and Walking Distance in Symptomatic Peripheral Arterial Disease in Elderly.

Authors:  Katarzyna Kropielnicka; Wioletta Dziubek; Katarzyna Bulińska; Małgorzata Stefańska; Joanna Wojcieszczyk-Latos; Ryszard Jasiński; Urszula Pilch; Grażyna Dąbrowska; Katarzyna Skórkowska-Telichowska; Dariusz Kałka; Agnieszka Janus; Katarzyna Zywar; Rafał Paszkowski; Anna Rachwalik; Marek Woźniewski; Andrzej Szuba
Journal:  Biomed Res Int       Date:  2018-09-23       Impact factor: 3.411

  6 in total
  1 in total

1.  The Influence of Treadmill Training on the Bioelectrical Activity of the Lower Limb Muscles in Patients with Intermittent Claudication.

Authors:  Anna Mika; Piotr Mika; Łukasz Oleksy; Anita Kulik
Journal:  J Clin Med       Date:  2022-02-27       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.